Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus

Diabetologia

Volumn 43, Issue 1, 2000, Pages 27-35

  Duvillard, L ^a,b   Pont, F ^a   Florentin, E ^a   Gambert, P ^a   Verges B ^a  

^a INSERM   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Apolipoprotein B; Insulin; Kinetic study; Leucine; Non insulin dependent diabetes mellitus; Stable isotope

Indexed keywords

APOLIPOPROTEIN B; GLIBENCLAMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERMEDIATE DENSITY LIPOPROTEIN; LEUCINE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METFORMIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIPOPROTEIN METABOLISM; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0034012271     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050004     Document Type: Article

References (42)

1. 1. Pyörälä K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 2: 464-524
2. 2. Kissebah AH, Alfarsi S, Evans DJ, Adams PW (1982) Integrated regulation of very low density lipoprotein triglycerides and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes 31: 217-225
3. 3. Taskinen MR, Beltz WF, Harper I et al. (1986) Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Study before and after sulfonylurea therapy. Diabetes 35: 1268-1277
4. 4. Howard BV, Abbott WGH, Egusa G, Taskinen MR (1987) Coordination of very-low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes mellitus. Am Heart J 113: 522-526
5. 5. Howard BV, Abbott WGH, Beltz WF et al. (1987) Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36: 870-877
6. 6. Cummings MH, Watts GF, Umpleby AM et al. (1995) Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 38: 959-967
7. 7. Kissebah AH, Alfarsi S, Evans DJ, Adams PW (1983) Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus. J Clin Invest 71: 655-667
8. 8. Taskinen MR, Kuusi T, Helve E, Nikkilä EA, Yki-Järvinen H (1988) Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 8: 168-177
9. 9. Bagdade JD, Buchanan WE, Kuusi T, Taskinen MR (1990) Persistent abnormalities in lipoprotein composition in non-insulin-dependent diabetes after intensive insulin therapy. Arterioscl 10: 232-239
10. 10. Taskinen MR, Packard CJ, Sheperd J (1990) Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39: 1017-1027
11. 11. Shen DC, Shien SM, Fuh MMT, Wu DA, Chen YDI, Reaven GM (1988) Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66: 580-583
12. 12. Vergès B, Rader D, Schaefer J et al. (1994) In vivo metabolism of apolipoprotein A-IV in severe hypertriglyceridemia: a combined radiotracer and stable isotope kinetic study. J Lipid Res 35: 2280-2291
13. 13. Pont F, Duvillard L, Maugeais C et al. (1997) Isotope Ratio Mass Spectrometry, compared with conventional mass spectrometry in kinetic studies at low and high enrichment levels: application to lipoprotein kinetics. Anal Biochem 248: 277-287
14. 14. Pont F, Duvillard L, Vergès B, Gambert P (1998) Development of compartmental models in stable isotope experiments: application to lipoprotein metabolism. Arterioscler Thromb Vasc Biol 18: 853-860
15. 15. Cobelli C, Toffolo G, Foster DM (1992) Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radio-active kinetic formalism. Am J Physiol 262: E968-E975
16. 16. Cobelli C, Toffolo G, Bier DM, Nosadini R (1987) Models to interpret kinetic data in stable isotope tracer studies. Am J Physiol 253: E551-E564
17. 17. Millar JS, Lichtenstein AH, Cuchel M et al. (1995) Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men. J Lipid Res 36: 1155-1167
18. 18. Maugeais C, Ouguerram K, Krempf M et al. (1996) A minimal model using stable isotopes to study the metabolism of apolipoprotein B-containing lipoproteins in humans. Diabetes Metab 22: 57-63
19. 19. Lagrost L, Athias A, Herbeth B et al. (1996) Opposite effects of cholesteryl transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. J Biol Chem 271: 19058-19065
20. 20. Viens L, Athias A, Lizard G et al. (1996) Effect of lipid transfer activity and lipolysis on low density lipoprotein (LDL) oxidizability: evidence for lipolysis-generated non-esterified fatty acids as inhibitors of LDL oxidation. J Lipid Res 37: 2179-2192
21. 21. Zilversmit DB (1979) Atherogenesis: a postprandial phenomenon. Circulation 60: 473-485
22. 22. Malmström R, Packard CJ, Caslake M et al. (1998) Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes 47: 779-787
23. 23. Cummings MH, Watts GF, Umpleby AM et al. (1995) Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 44: 1059-1065
24. 24. Malmström R, Packard CJ, Caslake M et al. (1997) Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40: 454-462
25. 25. Lewis GF, Uffelman KD, Szeto LW, Steiner G (1993) Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apo B production in normal weight and obese individuals. Diabetes 42: 833-842
26. 26. Taskinen MR, Beltz WF, Harper I et al. (1986) Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulfonylurea therapy. Diabetes 35: 1268-1277
27. 27. Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J (1984) Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest 74: 2178-2192
28. 28. Packard CJ, Gaw A, Demant T, Shepherd J (1995) Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. J Lipid Res 36: 172-187
29. 29. Steinbrecher UP, Witztum JL (1984) Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33: 130-134
30. 30. Krämer-Guth A, Quaschning T, Galle J et al. (1997) Structural and compositional modifications of diabetic low-density lipoproteins influence their mediator-mediated uptake by hepatocytes. Eur J Clin Invest 27: 460-468
31. 31. Nigon F, Lesnik P, Rouis M, Chapman J (1991) Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 32: 1741-1753
32. 32. Campos H, Arnold KS, Balestra ME, Innerarity TL, Krauss RM (1996) Differences in receptor binding of LDL subfractions. Arterioscler Thromb Vasc Biol 16: 794-801
33. 33. Aviram M, Lund-Katz S, Phillips MC, Chait A (1988) The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J Biol Chem 263: 16842-16848
34. 34. Henze K, Chait A (1981) Lysosomal enzyme activities and low density lipoprotein receptors in circulating mononuclear cells: effect of insulin therapy in diabetic patients. Diabetologia 20: 625-629
35. 35. Lopes-Virella MF, Klein RL, Virella G (1996) Modification of lipoproteins in diabetes. Diabetes Metab Rev 12: 69-90
36. 36. Lewis GF, Steiner G (1996) Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 12: 37-56
37. 37. Parthasarathy S, Santanam N (1994) Mechanism of oxidation, antioxydants, and atherosclerosis. Curr Opin Lipidol 5: 371-375
38. 38. Hunt JV (1997) Glyco-oxidation of LDL: a biochemist's perspective. In: Colaco C (ed.) The glycation hypothesis of atherosclerosis. Eds London Bioscience, Austin, pp 109-126
39. 39. Klein RL, Lyons TJ, Lopes-Virella MF (1990) Metabolism of very low and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages. Diabetologia 33: 299-305
40. 40. Klein RL, Laimins M, Lopes-Virella MF (1995) Isolation, characterization and metabolism of the glycated and non glycated subfractions of low density lipoproteins isolated from type 1 diabetic patients and non-diabetic subjects. Diabetes 44: 1093-1098
41. 41. Girona J, La Ville AE, Solà R, Plana N, Masana L (1999) Simvastatin decreases aldehyde production derived from lipoprotein oxidation. Am J Cardiol 83: 846-851
42. 42. Deegan P, Owens D, Collins P, Johnson A, Tomkin GH (1999) Association between low-density lipoprotein composition and its metabolism in non-insulin-dependent diabetes mellitus. Metabolism 48: 118-124